InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Hineline Lawrence J., Chief Financial Officer. Director active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 13 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €396k. History available since 21 December 2021. The latest transaction was filed on 7 March 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hineline Lawrence J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,514 shares@ US$66.267.1% of flowCommon StockSEC:0000950170-24-029582:0
13,132 sharesCommon StockSEC:0000950170-24-028819:0
7,455 sharesCommon StockSEC:0000950170-24-021569:0
11,183 shares0Common StockSEC:0000950170-24-011392:0
40,472 shares@ US$53.6336.0% of flowCommon StockSEC:0001209191-23-037968:0
15,663 shares0Common StockSEC:0001209191-23-018284:0
7,455 sharesCommon StockSEC:0001209191-23-013436:0
53,968 shares@ US$12.7311.6% of flowCommon StockSEC:0001209191-23-011994:0
65,164 shares@ US$15.4718.4% of flowCommon StockSEC:0001209191-22-051194:0
7,454 sharesCommon StockSEC:0001209191-22-013352:0
10,443 sharesCommon StockSEC:0001209191-22-012388:0
19,639 sharesCommon StockSEC:0001209191-22-002987:0
50,000 shares@ US$16.8615.5% of flowCommon StockSEC:0001209191-21-071174:0
13 of 13 declarations
About Hineline Lawrence J.
Hineline Lawrence J. is Directeur Financier at Intra-Cellular Therapies, Inc. The 13 filings recorded cover the period from 2021-12-23 to 2024-03-11, and among the recent filings observed, the sell amount is EUR 395996, with option exercises as the most common transaction type.
